Reinforcing and neurochemical effects of cannabinoid CB1 receptor agonists, but not cocaine, are altered by an adenosine A2A receptor antagonist

Key Modulatory Role of Presynaptic Adenosine A2AReceptors in Cortical Neurotransmission to the Striatal Direct Pathway

(2011) César Quiroz et al.   TheScientificWorldJOURNAL

Adenosine-cannabinoid receptor interactions. Implications for striatal function

(2010) Sergi Ferré et al.   BRITISH JOURNAL OF PHARMACOLOGY

Animal models of cannabinoid reward

(2010) Leigh V Panlilio et al.   BRITISH JOURNAL OF PHARMACOLOGY

Neurocircuitry of Addiction

(2009) George F Koob et al.   NEUROPSYCHOPHARMACOLOGY

Fatty Acid Amide Hydrolase Inhibition Heightens Anandamide Signaling Without Producing Reinforcing Effects in Primates

(2008) Zuzana Justinova et al.   BIOLOGICAL PSYCHIATRY

Looking for the role of cannabinoid receptor heteromers in striatal function

(2008) Sergi Ferré et al.   NEUROPHARMACOLOGY

Blockade of THC-Seeking Behavior and Relapse in Monkeys by the Cannabinoid CB1-Receptor Antagonist Rimonabant

(2008) Zuzana Justinova et al.   NEUROPSYCHOPHARMACOLOGY

Attenuation of cocaine self-administration in squirrel monkeys following repeated administration of the mGluR5 antagonist MPEP: comparison with dizocilpine

(2008) Donna M. Platt et al.   PSYCHOPHARMACOLOGY

Adenosine receptor antagonists for cognitive dysfunction: a review of animal studies

(2007) Reinaldo Naoto Takahashi   Frontiers in Bioscience-Landmark